Determination of changes in the basal metabolic rate and body composition of patients with chronic active and inactive hepatitis b infection using bioelectrical impedance analysis;Kronik aktif ve inaktif hepatit b enfeksiyonlu hastalarda biyoelektrik empedans analizi ile bazal metabolik hız ve vücut kompozisyonu deǧişimi

Turkish Journal of Medical Sciences

Volumn 42, Issue 2, 2012, Pages 237-243

  Unutmaz, Gökhan ^a   Tekin Koruk, Süda ^b   Sert, Cemil ^b  

^a Kilis State Hospital   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Bioelectric impedance; Body composition; Chronic hepatitis B

Indexed keywords

ADULT; AGE; ARTICLE; BASAL METABOLIC RATE; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IMPEDANCE; MALE;

EID: 84857476762     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1101-1447     Document Type: Article

References (28)

1. Dienstag JL., Chronic Viral Hepatitis. Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, Churchill Livingstone; 2010. p. 1593-617.
2. Obesity and overweight. World Health Organization (WHO); 2005. www.who.int/mediacentre/factsheets/fs311/en/index.html.
3. Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Obes Surg 2006; 16: 1584-93.
4. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-21.
5. Kendall MD, Harmel PA. The metabolic syndrome, type 2 diabetes and cardiovascular disease: Understanding the role of insulin resistance. Am J Manag Care 2002; 8: 635-53.
6. Liedtke RJ. Principles of bioelectrical impedance analysis. RJL Systems Publications, 1997. http://www.rjlsystems.com/research/bia-principles.html.
7. WHO. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, 3-5 June 1997. (Geneva: World Health Organisation, 1998; who/nut/ ncd/98: 1.)
8. Piccoli A. Identifi cation of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis. The Italian Hemodialysis-Bioelectrical Impedance Analysis (HD-BIA) Study Group. Kidney Int 1998; 53:1036-43.
9. Liedtke RJ. Fundamentals of bioelectrical impedance analysis. RJL Systems publications. 1998. http://www.rjlsysterns.com/research/biafundamentals.html.
10. World Health Organization. Introduction of Hepatitis B Vaccine into Childhood Immunization Services. Geneva, WHO, 2001.
11. Hatemi H, Turan N, Arik N, Yumuk V. Th e obesity and hypertension results in Turkey (TOHTA). J Endocrinol Directions 2002; 11: 1-16 (in Turkish).
12. Yumuk VD. National prevalence of obesity prevalence of obesity in Turkey. Obesity Reviews 2005; 6: 9-10.
13. Sencer E. 2001. Endocrinology, Metabolism and Nutrition Disorders. 1st. Ed., Nobel Bookstores, Istanbul, 2001 (in Turkish).
14. Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB. Lean body mass estimation by electrical impedance analysis. A four site cross validation study. Am J Clin Nutr 1988; 47: 7-14.
15. Cortez-Pinto H. Concluding remarks: metabolic syndrome, liver and HCV. Aliment Pharmacol Th er 2005; 22: 83-5.
16. Altiparmak E, Koklu S, Yalinkilic M, Yuksel O, Cicek B, Kayacetin E et al. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol 2005; 11: 3056-9.
17. Guida B, Laccetti R, Gerardi C, Trio R, Perrino NR, Strazzullo P et al. Bioelectrical impedance analysis and age-related diff erences of body composition in the elderly. Nutr Metab Cardiovasc Dis 2007; 17: 175-80.
18. Barbosa-Silva MC, Barros AJD, Wang J, Heymsfield SB, Pierson RN. Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr 2005; 82: 49-52.
19. Selberg O, Selberg D. Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 2002; 86: 509-16.
20. Pirlich M, Schütz T, Spachos T, Ertl S, Weiss ML, Lochs H et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000; 32: 1208-15.
21. Panella C, Guglielmi FW, Mastronutti T, Francavilla A. Wholebody and segmental bioelectrical parameters in chronic liver disease: Eff ect of gender and disease stages. Hepatology 1995; 21: 352-8.
22. Antaki F, French MM, Moonka DK, Gordon SC. Bioelectrical impedance analysis for the evaluation of hepatic fi brosis in patients with chronic hepatitis C infection. Dig Dis Sci 2008; 53: 1957-60
23. Kahraman A, Hilsenbeck J, Nyga M, Ertle J, Wree A, Plauth M et al. Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C. Virol J 2010; 7: 191.
24. Manns MP, Wedemeyer H, Cornberg M. Treating viral hepatitis C: effi cacy, side eff ects, and complications. Gut 2006; 55: 1350-9.
25. Garrow JS, Webster J. Qutelet's index (W/H2) as a measure of fatness. Int J Obes 1985; 9: 147-53.
26. Baumgartner RN, Chumlea C, Roche AF. Bioelectric impedance phase angle and body composition. Am J Clin Nutr 1988; 48: 16-23.
27. Oshima Y, Shiga T. Within-day variability of whole-body and segmental bioelectrical impedance in a standing position. Eur J Clin Nutr 2006; 60, 938-41.
28. Gallagher M, Walker KZ, O'Dea K. The infl uence of a breakfast meal on the assessment of body composition using bioelectrical impedance. Eur J Clin Nutr 1998; 52: 94-7.